Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Clinical manifestation of non-ketotic hyperglycemia chorea: A case report and literature review

Wang W, Tang X, Feng H, Sun F, Liu L, Rajah GB, Yu F.

Medicine (Baltimore). 2020 May 29;99(22):e19801. doi: 10.1097/MD.0000000000019801.

Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases

John A, Kubosumi A, Reddy PH.

Cells. 2020 May 28;9(6):1345. doi: 10.3390/cells9061345.

Functional gait disorders: A sign-based approach

Nonnekes J, Růžička E, Serranová T, Reich SG, Bloem BR, Hallett M.

Neurology. 2020 Jun 16;94(24):1093-1099. doi: 10.1212/WNL.0000000000009649. Epub 2020 Jun 1.

Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease

Smaga I, Fierro D, Mesa J, Filip M, Knackstedt LA.

Neurosci Biobehav Rev. 2020 Aug;115:116-130. doi: 10.1016/j.neubiorev.2020.05.016. Epub 2020 May 30.

Molecular Targets from Traditional Medicines for Neuroprotection in Human Neurodegenerative Diseases

Deolankar SC, Modi PK, Subbannayya Y, Pervaje R, Prasad TSK.

OMICS. 2020 Jul;24(7):394-403. doi: 10.1089/omi.2020.0033. Epub 2020 Jun 2.

S100A6 and Its Brain Ligands in Neurodegenerative Disorders

Filipek A, Leśniak W.

Int J Mol Sci. 2020 Jun 1;21(11):3979. doi: 10.3390/ijms21113979.

Additional Safety and Exploratory Efficacy Data at 48 and 60 Months from Open-HART, an Open-Label Extension Study of Pridopidine in Huntington Disease

McGarry A, Auinger P, Kieburtz K, Geva M, Mehra M, Abler V, Grachev ID, Gordon MF, Savola JM, Gandhi S, Papapetropoulos S, Hayden M.

J Huntingtons Dis. 2020;9(2):173-184. doi: 10.3233/JHD-190393.

Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk

Kayed R, Dettmer U, Lesné SE.

J Parkinsons Dis. 2020;10(3):791-818. doi: 10.3233/JPD-201965.

Glia in neurodegeneration: Drivers of disease or along for the ride?

Gleichman AJ, Carmichael ST.

Neurobiol Dis. 2020 Aug;142:104957. doi: 10.1016/j.nbd.2020.104957. Epub 2020 Jun 6.

Why Woody got the blues: The neurobiology of depression in Huntington's disease

Gubert C, Renoir T, Hannan AJ.

Neurobiol Dis. 2020 Aug;142:104958. doi: 10.1016/j.nbd.2020.104958. Epub 2020 Jun 8.

The role of nicotinic cholinergic neurotransmission in delusional thinking

Caton M, Ochoa ELM, Barrantes FJ.

NPJ Schizophr. 2020 Jun 12;6(1):16. doi: 10.1038/s41537-020-0105-9.

Huntington's disease as an unexpected cause of deafness with dystonia and chorea

Souza PVS, Pedroso JL, Pinto WBVR, Barsottini OGP.

Parkinsonism Relat Disord. 2020 Jul;76:10-12. doi: 10.1016/j.parkreldis.2020.05.039. Epub 2020 Jun 1.

New Onset Chorea in a Previously Healthy 7-Year-Old

Delaney MA, Rueda MS, Strelzik J, Yonts A, Harik N.

J Pediatr. 2020 Aug;223:216-217. doi: 10.1016/j.jpeds.2020.04.053. Epub 2020 Jun 10.

A Critical Review of White Matter Changes in Huntington's Disease

Casella C, Lipp I, Rosser A, Jones DK, Metzler-Baddeley C.

Mov Disord. 2020 Aug;35(8):1302-1311. doi: 10.1002/mds.28109. Epub 2020 Jun 15.

Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective

Björklund A, Parmar M.

Front Cell Neurosci. 2020 May 29;14:146. doi: 10.3389/fncel.2020.00146. eCollection 2020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias